Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LF.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LF.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LF.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LF.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LF.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KR.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KR.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KR.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KR.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KR.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KR.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.7.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
JN.1.7.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.7.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
JN.1.7.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.7.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
JN.1.7.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
KP.2.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.2.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.2.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.2.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
KR.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KR.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
KR.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KR.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
KR.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.59EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.59ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.59ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.59EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.59EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.59ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LG.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LG.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LG.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used